Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This signals a new release of the ClinicalTrials.gov interface/backend, and the visible study content remains unchanged.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page now includes a line indicating 2017 U.S. NIH grant/contract funding in the study's information.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page update adds new metadata and navigation references related to Gilead's clinical trials website, study documents, IPD planning, and publications, plus associated MeSH terms, enriching contextual references and external links for the Magrolimab study.SummaryDifference91%

- Check38 days agoChange DetectedCore study details and linked documents were removed, including intervention names, arms, and locations, along with several key study documents and metadata that described how the trial is organized and where it takes place.SummaryDifference20%

- Check45 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4. This indicates a minor patch to the page's versioning rather than a substantive content update.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a new revision tag Revision: v3.6.3, replacing the previous Revision: v3.6.0. The change appears to be a minor page version update and does not affect the study details.SummaryDifference0.0%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.